Grant: Master's Award: Canada Graduate Scholarships
University of British Columbia
$17,500.00
An Artificial Intelligence (AI) Platform for Classification of Ovarian Tumors
EF 2021-22
Résumé
Ovarian cancer ranks fifth in cancer deaths among women (~1,800 and ~14,000deaths/year in Canada and U.S., respectively), accounting for more deaths than any other cancer of the female reproductive system. There are 5 major subtypes of epithelial ovarian cancer. Each subtype is associated with a distinct set of mutated genes, cellular structures, and responds differently to chemotherapy. However, their treatment remains mostly the same, centered around surgery and chemotherapy. The lack of subtype specific treatment can be attributed to the challenges in sub-classifying ovarian cancer. One major challenge in subclassifying ovarian cancer is poor diagnosis reproducibility.Histopathology (the microscopic study of diseased tissue) has been an important tool incancer diagnosis. Histopathology images capture cellular phenotypes which reflect the effect of DNA alterations on cancer cells. However, sub-classification based on histopatological imagesis often hampered by disagreement among independent observers and poor diagnostic reproducibility. To address this issue,I intend to build a novel artificial intelligence (AI)-based platform for an automated analysis of histopathology slides and ovarian cancer biomarker discovery.Recent applications of deep learning methods (e.g. convoluted neural networks (CNNs)) on image data have demonstrated the ability of CNN to learn predictive features from raw imaging data.I will explore different architectures of CNNs to accurately identify the subtypes of ovarian cancer and choose the best-performing classifer by measuring its performance on held-out test datasets.I expect this research to contribute to the identification of ovarian cancer biomarkers for patient stratification and individualized treatment.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
466562
Name
Shi Xin Ping
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
An Artificial Intelligence (AI) Platform for Classification of Ovarian Tumors
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Artificial Intelligence/Machine Learning; Bioinformatics; Cancer Genomics; Computational Biology; Computational Pathology; Ovarian Cancer; Signal/Image Processing
Abstract
Ovarian cancer ranks fifth in cancer deaths among women (~1,800 and ~14,000deaths/year in Canada and U.S., respectively), accounting for more deaths than any other cancer of the female reproductive system. There are 5 major subtypes of epithelial ovarian cancer. Each subtype is associated with a distinct set of mutated genes, cellular structures, and responds differently to chemotherapy. However, their treatment remains mostly the same, centered around surgery and chemotherapy. The lack of subtype specific treatment can be attributed to the challenges in sub-classifying ovarian cancer. One major challenge in subclassifying ovarian cancer is poor diagnosis reproducibility.Histopathology (the microscopic study of diseased tissue) has been an important tool incancer diagnosis. Histopathology images capture cellular phenotypes which reflect the effect of DNA alterations on cancer cells. However, sub-classification based on histopatological imagesis often hampered by disagreement among independent observers and poor diagnostic reproducibility. To address this issue,I intend to build a novel artificial intelligence (AI)-based platform for an automated analysis of histopathology slides and ovarian cancer biomarker discovery.Recent applications of deep learning methods (e.g. convoluted neural networks (CNNs)) on image data have demonstrated the ability of CNN to learn predictive features from raw imaging data.I will explore different architectures of CNNs to accurately identify the subtypes of ovarian cancer and choose the best-performing classifer by measuring its performance on held-out test datasets.I expect this research to contribute to the identification of ovarian cancer biomarkers for patient stratification and individualized treatment.
Competitiondate
202112
Approvedterm2
1 yr 0 mth
Pinamesdelim
Shi, Xin Ping
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~